<DOC>
	<DOC>NCT01845090</DOC>
	<brief_summary>To compare the effect of lanthanum carbonate with calcium carbonate on serum FGF23 levels in hemodialysis patients.</brief_summary>
	<brief_title>The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23</brief_title>
	<detailed_description>The investigators enrolled patients on maintenance hemodialysis and randomized them to two groups. One group will receive lanthanum carbonate and another group will receive calcium carbonate. The investigators will compare serum FGF23 levels between two groups after they receive above medication for 6 months.</detailed_description>
	<mesh_term>Calcium, Dietary</mesh_term>
	<mesh_term>Calcium Carbonate</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>Age &gt; 18 years old Chronic renal failure on maintenance hemodialysis 3 times a week for at least 3 months Serum calcium:810.5 mg/dL Serum phosphate:3.56 mg/dL(before washout period) Serum phosphate â‰§6 mg/dL after washout period Serum iPTH: 150600 pg/mL Diabetes mellitus Post parathyroidectomy Life expectancy&lt; 6 months Liver disease(hepatitis B,C or liver dysfunction) Severe gastrointestinal disorders or other severe comorbidity Poor compliance Intolerance to lanthanum or calcium carbonate Active infection Malnutrition(serum albumin&lt;3 g/dL or clinical assessment) Kt/V&lt; 1.2 (inadequate dialysis) Serum phosphate&gt;7.5 mg/dL after washout period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>